Craft

Advanced
Livanova

Livanova

Stock Price

$53

2024-10-29

Market Capitalization

$2.9 B

2024-10-29

Revenue

$1.4 B

FY, 2025

Livanova Summary

Company Summary

Overview
LivaNova is a global medical technology company. The company provides cardiac surgery, neuromodulation, and cardiac rhythm management solutions.
Type
Public
Status
Active
Founded
2015
HQ
London, GB | view all locations
Website
http://www.livanova.com/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Table of Contents

Key People

  • Damien McDonald

    Damien McDonald, Chief Executive Officer and Director

    • Daniel Moore

      Daniel Moore, Chairman

      • Francesco Bianchi

        Francesco Bianchi, Director

        • Keyna Skeffington

          Keyna Skeffington, Senior Vice President, General Counsel

          LocationsView all

          20 locations detected

          • London, England HQ

            United Kingdom

            20 Eastbourne Terrace

          • Houston, TX

            United States

            100 Cyberonics Blvd

          • Dandenong South, VIC

            Australia

            16/18 Hydrive Cl

          • Wien, Wien

            Austria

            Schottengasse 1

          • Markham, ON

            Canada

            280 Hillmount Rd #8

          • Bogotá, Bogotá

            Colombia

            Cra. 33 ##15-39

          and 14 others

          Livanova Financials

          Summary Financials

          Revenue (Q1, 2026)
          $362.3M
          Gross profit (Q1, 2026)
          $243.7M
          Net income (Q1, 2026)
          $22.3M
          Cash (Q1, 2026)
          $539.7M
          EBIT (Q1, 2026)
          $41.5M
          Enterprise value
          $2.7B

          Competitors and Similar Companies

          Compare competitors

          Footer menu

          Product

          Solutions

          Resources

          Company

          © Craft.co 2026
          Share price data provided by IEX